NDC 52544-348 - Triamterene and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52544-348
- Package NDCs from labels
- 52544-348-30, 52544-348-01, 52544-348-05, 52544-348-10
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamterene and Hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets USP Rx only | Watson Laboratories, Inc. | 2008-01-24 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52544-348-01 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 52544-348-05 | Triamterene and Hydrochlorothiazide | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 52544-348-10 | Triamterene and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 52544-348-30 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 36fbc5fc-4a75-4aa3-bed1-78944135ae11 | 2024-05-17 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1884db5f-72b5-6b0c-e063-6394a90a0e49 | 2024-05-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb08103-04ee-47a6-a9ad-290e169feb51 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | c8740506-c679-4c41-a96a-8ddbcddd72c6 | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | abf2fe45-8b69-4d3c-981e-289c0aa3e98b | 2024-05-01 | Warnings, Adverse reactions | ANDA071851 310818 310812 WS821Z52LQ 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | c6ed6f74-0eca-4f99-8c7e-dd3f56167f01 | 2024-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Fosinopril Sodium and Hydrochlorothiazide | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 35019655-9a30-4305-a262-936ad0e73071 | 2024-04-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE | QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 50a58159-9572-4445-9859-b392632597da | 2024-04-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 98a58b54-bcf2-4726-800a-facf48d9155f | 2024-04-25 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | cba87d5b-9302-7b2c-e053-2a95a90a7f9d | 2024-04-17 | Boxed warning, Adverse reactions | WS821Z52LQ 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 39d4dbd3-8f24-4898-a240-e94e06fa229a | 2024-04-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 4c0b028d-f0f4-417f-a068-dca24e56113f | 2024-04-10 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | a6ebafdc-4301-4d6c-b578-b3212648b13a | 2024-04-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 5ca13106-f68b-4894-aca2-03e74fff350c | 2024-04-03 | Boxed warning, Adverse reactions | WS821Z52LQ 0J48LPH2TH |
| Clear Eyes Natural Tears | POLYVINYL ALCOHOL AND POVIDONE | Prestige Brands Holdings, Inc. | efba3eb0-798d-4635-b19b-4970e45b3cc9 | 2024-04-01 | Warnings | FZ989GH94E |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | BluePoint Laboratories | b8a55c23-b509-4790-88fa-9dc9bacd4bbe | 2024-03-29 | Warnings, Adverse reactions | ANDA071851 310818 310812 WS821Z52LQ 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | cb7712f3-9a0b-442d-859d-8be5e6e2529a | 2024-03-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2e4eee3a-fe0c-44aa-8ff1-b14b07a0c5bc | 2024-03-27 | Warnings, Adverse reactions | 0J48LPH2TH |
| REFRESH CLASSIC | POLYVINYL ALCOHOL, POVIDONE | A-S Medication Solutions | 3bf6193c-56db-45ad-844c-58eb8c33cba9 | 2024-03-14 | Warnings | FZ989GH94E |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | ff448eb4-b48f-46f5-ac30-f03aad08f9f5 | 2024-03-01 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.